Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

Conclusions Switch maintenance therapy with S-1 after induction therapy with carboplatin andnab-paclitaxel was associated with moderate efficacy and acceptable safety and may represent a feasible treatment option for patients with advanced SCC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research